163 related articles for article (PubMed ID: 29893051)
41. Actinic keratoses: Natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial.
Criscione VD; Weinstock MA; Naylor MF; Luque C; Eide MJ; Bingham SF;
Cancer; 2009 Jun; 115(11):2523-30. PubMed ID: 19382202
[TBL] [Abstract][Full Text] [Related]
42. Actinic keratosis: facts and controversies.
Ko CJ
Clin Dermatol; 2010; 28(3):249-53. PubMed ID: 20541675
[TBL] [Abstract][Full Text] [Related]
43. Nonablative fractional photothermolysis for facial actinic keratoses: 6-month follow-up with histologic evaluation.
Katz TM; Goldberg LH; Marquez D; Kimyai-Asadi A; Polder KD; Landau JM; Friedman PM
J Am Acad Dermatol; 2011 Aug; 65(2):349-356. PubMed ID: 21621294
[TBL] [Abstract][Full Text] [Related]
44. [Not Available].
Perrot JL; Tognetti L; Habougit C; Biron Schneider AC; Couzan C; Rubegni P; Cinotti E;
Ann Dermatol Venereol; 2019 May; 146 Suppl 2():IIS16-IIS21. PubMed ID: 31133225
[TBL] [Abstract][Full Text] [Related]
45. Actinic keratoses: past, present and future.
Fenske NA; Spencer J; Adam F
J Drugs Dermatol; 2010 May; 9(5 Suppl ODAC Conf Pt 1):s45-9. PubMed ID: 20518359
[TBL] [Abstract][Full Text] [Related]
46. Topical diclofenac 3% gel plus cryotherapy for treatment of multiple and recurrent actinic keratoses.
Mastrolonardo M
Clin Exp Dermatol; 2009 Jan; 34(1):33-5. PubMed ID: 18616726
[TBL] [Abstract][Full Text] [Related]
47. A new vision of actinic keratosis beyond visible clinical lesions.
Malvehy J
J Eur Acad Dermatol Venereol; 2015 Jan; 29 Suppl 1():3-8. PubMed ID: 25470718
[TBL] [Abstract][Full Text] [Related]
48. A prospective randomized exploratory study comparing the efficacy of once-daily topical 0.5% 5-fluorouracil in combination with 10.0% salicylic acid (5-FU/SA) vs. cryosurgery for the treatment of hyperkeratotic actinic keratosis.
Simon JC; Dominicus R; Karl L; Rodríguez R; Willers C; Dirschka T
J Eur Acad Dermatol Venereol; 2015 May; 29(5):881-9. PubMed ID: 25257941
[TBL] [Abstract][Full Text] [Related]
49. Progression of actinic keratosis to squamous cell carcinoma revisited: clinical and treatment implications.
Feldman SR; Fleischer AB
Cutis; 2011 Apr; 87(4):201-7. PubMed ID: 21644496
[TBL] [Abstract][Full Text] [Related]
50. Efficacy of cryosurgery and 5-fluorouracil cream 0.5% combination therapy for the treatment of actinic keratosis.
Hoover WD; Jorizzo JL; Clark AR; Feldman SR; Holbrook J; Huang KE
Cutis; 2014 Nov; 94(5):255-9. PubMed ID: 25474455
[TBL] [Abstract][Full Text] [Related]
51. Reflectance confocal microscopy criteria for squamous cell carcinomas and actinic keratoses.
Rishpon A; Kim N; Scope A; Porges L; Oliviero MC; Braun RP; Marghoob AA; Fox CA; Rabinovitz HS
Arch Dermatol; 2009 Jul; 145(7):766-72. PubMed ID: 19620557
[TBL] [Abstract][Full Text] [Related]
52. The paradigm shift in treating actinic keratosis: a comprehensive strategy.
Stockfleth E
J Drugs Dermatol; 2012 Dec; 11(12):1462-7. PubMed ID: 23377517
[TBL] [Abstract][Full Text] [Related]
53. Management of actinic keratosis at specific body sites in patients at high risk of carcinoma lesions: expert consensus from the AKTeam™ of expert clinicians.
Richard MA; Amici JM; Basset-Seguin N; Claudel JP; Cribier B; Dreno B
J Eur Acad Dermatol Venereol; 2018 Mar; 32(3):339-346. PubMed ID: 29235161
[TBL] [Abstract][Full Text] [Related]
54. Dermatoscopic Patterns of Nonfacial Actinic Keratosis: Characterization of Pigmented and Nonpigmented Lesions.
Reinehr CPH; Garbin GC; Bakos RM
Dermatol Surg; 2017 Nov; 43(11):1385-1391. PubMed ID: 28538027
[TBL] [Abstract][Full Text] [Related]
55. The importance of treating the field in actinic keratosis.
Stockfleth E
J Eur Acad Dermatol Venereol; 2017 Mar; 31 Suppl 2():8-11. PubMed ID: 28263021
[TBL] [Abstract][Full Text] [Related]
56. Treatment considerations in actinic keratosis.
Goldenberg G
J Eur Acad Dermatol Venereol; 2017 Mar; 31 Suppl 2():12-16. PubMed ID: 28263018
[TBL] [Abstract][Full Text] [Related]
57. Combining field therapies for actinic keratoses: novel approaches that intensify photodynamic therapy.
Kaminska EC; Tsoukas MM
Skinmed; 2013; 11(1):54-8. PubMed ID: 23540080
[TBL] [Abstract][Full Text] [Related]
58. Efficacy of Ingenol Mebutate in the Treatment of Actinic Keratoses: A Pre- and Posttreatment Dermoscopic Comparative Analysis.
Carbotti M; Coppola R; Zanframundo S; Devirgiliis V; Panasiti V
Biomed Res Int; 2018; 2018():4381019. PubMed ID: 30246021
[TBL] [Abstract][Full Text] [Related]
59. What is the role of field-directed therapy in the treatment of actinic keratosis? Part 2: Commonly used field-directed and lesion-directed therapies.
Berman B; Cohen DE; Amini S
Cutis; 2012 Jun; 89(6):294-301. PubMed ID: 22838095
[TBL] [Abstract][Full Text] [Related]
60. Evaluation and treatment monitoring of actinic keratosis using line-field confocal optical coherence tomography.
Pathak GN; Sanabria B; Caetano VD; Rafiq B; Rao BK
Skin Res Technol; 2024 May; 30(5):e13726. PubMed ID: 38696227
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
